[Federal Register Volume 81, Number 112 (Friday, June 10, 2016)]
[Notices]
[Pages 37617-37618]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-13725]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Innovative 
Approaches to the Prevention and Early Detection of Small Cell Lung 
Cancer (U01).
    Date: July 18, 2016.
    Time: 7:30 p.m. to 10:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic 
Development and Mechanisms of Resistance (U01).
    Date: July 19, 2016.
    Time: 8:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small-Cell Lung Cancer (SCLC) Consortium: Coordinating Center 
(U24).

[[Page 37618]]

    Date: July 19, 2016.
    Time: 1:30 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Timothy C. Meeker, MD, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 9609 Medical 
Center Drive, Room 7W624, Rockville, MD 20892-9750, 240-276-6464, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Clinical Center Collaborative Research (U01).
    Date: July 22, 2016.
    Time: 9:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute, Shady Grove, 9609 Medical 
Center Drive, Room 2W914, Rockville, MD 20850 (Telephone Conference 
Call).
    Contact Person: Caron A. Lyman, Ph.D., Chief, Scientific Review 
Officer, Research Programs Review, Branch Division of Extramural 
Activities, National Cancer Institute, 9609 Medical Center Drive, 
Room 7W126, Rockville, MD 20892-9750, 240-276-6348, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: June 6, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-13725 Filed 6-9-16; 8:45 am]
BILLING CODE 4140-01-P